Nanda Parvathaneni

[PurnaChander @Purnachanderp]

This shows the maturity in worshiping God. Wonderful treat to eyes too ...

[National Cancer Institute @theNCI]

Many different types of #immunotherapy are used to treat cancer: https://t.co/JJVqM4dUuI

[Stojdl Lab @StojdlLab]

Improving #cancer #immunotherapy outcomes with anti-angiogenic treatments (and vice versa): https://t.co/T1jCozqczm via @NatRevClinOncol @UofT Image credit: Khan and Kerbel 2018

[National Cancer Institute @theNCI]

What is CAR T-cell therapy? It involves changing a patient’s immune cells in the lab so they'll attack cancer cells https://t.co/V8BAGQ6pyv

[National Cancer Institute @theNCI]

Some viruses tend to infect and kill tumor cells. Researchers are developing these tumor-targeting viruses as potential cancer treatments: https://t.co/oZum5S3RWe

[JAMA Oncology @JAMAOnc]

Selective inhibitor of mutant isocitrate dehydrogenase 2 (IDH2) enasidenib promotes differentiat’n of leukemic #myeloblasts, can cause life-threatening differentiation syndrome in ~12% of pts receiving it for relapsed/refractory #AML. https://t.co/11GGjtFc3r

[Nature Reviews Cancer @NatureRevCancer]

Check out our NEW article by Jan Burger & Adrian Wiestner on targeting B cell receptor signalling in #cancer. It discusses how inhibitors of this signalling are changing treatment outcomes for patients with B cell neoplasms.
https://t.co/f3ycfvWH71

[Nature Reviews Cancer @NatureRevCancer]

Find out what Thomas Brabletz, Raghu Kalluri, Angela Nieto and Robert Weinberg have to say on the role of EMT in #cancer! Take a look….
https://t.co/Kf5XtyY8HM

[National Cancer Institute @theNCI]

The timing and sequence of two immunotherapy drugs are critical when using in combination, a mouse study suggests: https://t.co/vwv8YAiznC

[National Cancer Institute @theNCI]

Cancer cells differ from normal cells in many ways that allow them to grow out of control and become invasive: https://t.co/lRFtYIbS2C

[National Cancer Institute @theNCI]

Treating cancer with CAR T-cells is like giving patients a “living drug.” https://t.co/jJFsDiRiHr #immunotherapy #CARTcells #ImmunoOnc

[Nature Reviews Cancer @NatureRevCancer]

Our Analysis article on preclinical mouse tumour models: current practices, challenges & improvements is free to view for a month! Check it out!
https://t.co/PaoBwqMLqD

[National Cancer Institute @theNCI]

Clinical trial aims to learn if adding #immunotherapy and vaccine to #glioblastoma therapy increases survival rate: https://t.co/6vZuwSbYLh

[National Cancer Institute @theNCI]

What is CAR T-cell therapy? It involves changing a patient’s immune cells in the lab so they'll attack cancer cells https://t.co/V8BAGQ6pyv

[National Cancer Institute @theNCI]

The timing and sequence of two immunotherapy drugs are critical when using in combination, a mouse study suggests: https://t.co/vwv8YAiznC

[National Cancer Institute @theNCI]

With FDA approval for advanced lymphoma, second CAR T-cell therapy enters the clinic: https://t.co/R7ikEFu6MR #immunotherapy @NCIResearchCtr

[JAMA Oncology @JAMAOnc]

Chimeric antigen receptor (CAR) T-cell therapy for #cancer: an explanation for patients. https://t.co/YZGgNivpUN

[National Cancer Institute @theNCI]

What is CAR T-cell therapy? It involves changing a patient’s immune cells in the lab so they'll attack cancer cells https://t.co/V8BAGQ6pyv

[Cancer Cell @Cancer_Cell]

Still time to register for the free LabLinks on Metastasis: Translating Biology into Therapy, Nov 8 in New York City https://t.co/NBf0UQzKTx

[Wafik S. El-Deiry, MD, PhD, FACP @weldeiry]

New Compound Targets Metastatic Cancer Cells - NFCR https://t.co/ODbsCKHlBx